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Summary.-Canine melanoma has been transplanted to allogeneic neonatal recipi-
ents receiving continuous immunosuppression with anti-lymphocyte serum. One
spontaneous melanoma was directly transplanted into 8 recipients, 6 of which
developed tumours. 5/5 melanoma cell cultures were transplantable, with 19 tumour
takes in 31 allogeneic recipients. Serial passage was performed in the case of two
melanomas. Tumour development required continuous immunosuppression and
the site was dependent upon the route ofinoculation and other factors. Transplanted
cell cultures were all amelanotic in vitro and in vivo, except in the case of one melano-
ma which reverted to a melanotic morphology after in vivo growth.
CANINE spontaneous neoplasms have
been infrequently transplanted, and suc-
cess rates were low when irradiation or
drug immunosuppression were employed
(Allam et al., 1954; Nielsen and Cole, 1961;
Moldovanu et al., 1966). Intrafoetal inoc-
ulation or immunosuppression with anti-
lymphocyte serum (ALS) have yielded
better results with canine osteosarcoma
(Owen, 1969) and lymphosarcoma (Owen
and Nielsen, 1968). Canine oral papil-
loma, mast cell leukaemia (Lombard,
Moloney and Rickard, 1963) and the
transmissible venereal tumour (Epstein
and Bennett, 1974) are transplantable
without immunosuppression. In many
respects canine melanoma provides a
valuable comparative model but has not
previously been transplanted. Successful
allogeneic transplantation into new-born
ALS-treated dogs is now reported.
MATERIALS AND METHODS
Melanoma cells.-Spontaneous cases of
canine melanoma, involving the oropharynx
or metastasizing to the regional lymphnodes,
were excised aseptically under general anaes-
thesia. Cell suspensions for inoculation were
prepared by finely cutting the melanoma
tissue and pressing the cells through a
150-,tm aperture sieve. Cells were either
injected immediatelyafter preparation orafter
cryopreservation at -196TC in medium
containing 10% DMSO.
Melanoma cells for in vitro cultivation
were dissociated by sieving or by trypsini-
zation. Cell cultures were grown as adherent
monolayers in medium 199 or RPMI 1640
plus penicillin/streptomycin and 10% calf or
foetal bovine serum and serially subcultured.
Prior to inoculation, melanoma cells were
detached with trypsin plus EDTA solution,
washed and resuspended in Hanks' BSS.
Recipients.-Pregnant mongrel bitches
were barrier-maintained and, following par-
turition, the newborn recipient dogs were
placed on an immunosuppressive course of
ALS treatment as previously reported (Owen,
1969) unless otherwise stated.
After estimating total and viable (trypan-
blue-excluding) cell counts, melanoma cell
suspensions were injected in Hanks' BSS via
the jugular vein or s.c. on the lateral abdo-
men. Following inoculation, recipients w'ere
regularly checked for palpable s.c. tumour
growth or symptoms of lethargy or dyspnoea
indicative of systemic tumour growth.
Thoracic radiography enabled early pul-
monary tumour formation to be detected.MELANOMA GRAFTS IN ALS DOGS
Spontaneous melanoma VI
C
Cell suspension
I_
108 cells i.v. plus
108 cells s.c.
2/2 dogs with lung and
s.c. tumours after 3 wks
2-5 X 107cells i.v. 108celIs s.c.
4 4
2/2 dogs with lung
tumours after 33 days
-4
Cryopreserved at -196 C
108cells i.v. 108 cells i.v. plus
108cells s.c.
2/4 dogs with lung
tumours after 3-7 months
2/2 dogs with
tumours after
7 weeks
2/2 dogs with s.c.
tumours at 35 and 38 days
I
1 *2 X 107 celIs i.v.
plus 1 o8 cells X 2 s.c.
1/1 dog with lung and
s.c. tumours after
13 weeks
Fi'n. 1. Transplaintation and iin vivo passage of a spontaneous canine melanoma.
inoculation. s.c. = subcutaneous inoculation.
RESULTS
Transplantation directly from spontaneous
melanomas
In a series of 16 dogs inoculated with
viable cells from 5 canine melanomas,
tumour growth was observed in 6 animals.
All successful transplants were derived
from one donor (VI) either as fresh or
cryopreserved cell suspensions (Fig.1).
J.v. injection produced miliary lung tum-
ours and myocardial infiltration along the
coronary vessels. Pulmonary tumours
exhibited various degrees ofpigmentation.
Some dogs also developed melanomas in
the pancreas, mesentery, pleura andlymph
nodes. S.c. inoculation produced large
melanotic tumours which were locally
invasive and, in one recipient, present in
distant sites. Development time for de-
tectable growth ranged from 3-13 weeks,
except for one dog which remained
clinically normal until euthanasia at 7
months of age, whenpulmonary melanoma
deposits were found. All tumours were
confirmed histologically as melanomas.
Subsequently, three serial in vivo passages
were obtained with inoculation by the i.v.
and s.c. routes (Fig. 1). All the remaining
melanomas failed to grow after i.v. or s.c.
inoculation of 108 tumour cells into ALS-
treated recipients.
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FIG. 2. Amelanotic melanoma cells (H71-1843) in vitro. Cells show a bipolar or multipolar morphology
with the presence of some multinucleate and giant cells. Giemsa stain. x 320.
Transplantation of canine melanoma cells
grown in vitro
Melanoma cell cultures were estab-
lished from spontaneous amelanotic (H71-
1843, H73-1357) andmelanotic melanomas
(VI, H73-858). Following continuous
subcultivation in vitro, established cul-
tures became amelanotic (Fig. 2) but
retained other features of malignant
melanoma cells (Betton, 1975). The RVC
347 melanoma cell line (Kasza, 1964) was
also generously provided for study.
The results of inoculation of 5 canine
melanoma culturesintoimmunosuppressed
recipients are summarized in the Table.
All the melanoma cultures tested showed
in vivo growth in a proportion ofrecipients,
although V1 tumours showed regression
after the initial 3 week growth phase.
Iv. inoculation produced tumour
growth in the lungs and frequently the
myocardium and in some cases in the
pleura, peritoneum, bone, pancreas, thy-
mus (Fig.3), pelvic and perirenal lymph
nodes and the central nervous system.
Miliary s.c. deposits of melanoma have
also been observed. Histopathological
examination revealed the presence of
anaplastic melanoma cells with frequent
mitotic figures and devoid of melanin
except in the case of H73-858 cells.
Although the latter cells had become
amelanotic during growth in vitro, the
transplanted tumours were all heavily
pigmented in vivo in s.c. and disseminated
visceral sites.
S.c. tumour inoculation produced
rapidly-growing localized tumours (Fig. 4),
often locally invasive and sometimes
ulcerating. Distant tumours were not
observed, except in the case of H73-858
cells, when some lung tumours also
developed. In the case of H71-1843,
melanoma cells from transplanted tumour
tissue were maintained in tissue culture
for two passages and were subsequently
capable of further growth in vivo when re-
inoculated.
376MELANOMA GRAFTS IN ALS DOGS
TABLE--Transplantation of Melanoma Cells grown in vitro into ALS-treated
Allogeneic Recipients
No. of cells injected
iv. S.C.
5x 106+5x 106
6 6x 106
11x 107+1l1 x 107
5x106+3 4x 106
2x 107
9x 106+9x 106
1 x 107
7 4x 106
1x 107+7 4x 106
8 4x 107+3x 108
8 4x 107
1 X 10 -
1 X 108
5x 107
1 x 107
1 x 107+1 x 107
1-8x 107
1 X 108
9 4x 107+1 5x 108
5 x 107
3 x 107
3 x 107
Growth
in vivo
0/1
0/1
1/2
0/1
2/3
Total 3/8
1/1
0/1
0/1
0/1
1/1
1/1
1/1
1/1
1/1
1/1
1/1
Total 8/11
1/2*
0/2
1/1
1/1*
1/1*
Total 4/7
1/1
0/1
Total 1/2
2-5 x 107 1/1
4x 107 1/1
3x 107 1/1
Total 3/3
Overall Total: 19/31 Recipients positive
Development
time
24 days (regr.)
21 days (regr.)
13 days
3 weeks
3 weeks
3 weeks
3 weeks
3 weeks
3 weeks
3 weeks
16 weeks
3 weeks
7 weeks
20 weeks
6 wveeks
13 weeks
14 weeks
12 weeks
i.v. = intravenous inoculation
s.c. = subcutaneous inoculation
regr. = regressed
* _ identically treated littermate controls not receiving ALS showed no tumour growth
Immunosuppression with ALS was
found to be essential for tumour growth,
as rapid regression of pulmonary and s.c.
transplanted melanomas was observed
when ALS treatment was withdrawn. In
the case of RVC 347, 0/4 recipients not
receiving ALS developed melanomas,
whereas 4/7 immunosuppressed recipients
became tumour bearers (Table). An un-
usual feature of transplanted RVC 347
cells was the long latent period in 3
recipients, in which development of lung
tumours was minimal, permitting sur-
vival until the development of tumours in
the bone, central nervous system and other
sites was observed. Osteolytic tumours
were observed in the ribs and in the
maxilla eroding the dental alveoli, closely
resembling spontaneous primary oral
melanomas.
DISCUSSION
Using immunosuppression of newborn
dogs with ALS in the present series, it was
possible to transplant 1/5 spontaneous
melanomas directly (6/16 dogs inoculated)
and 5/5 melanoma cell cultures produced
growth in vivo in 19/31 recipients. The
apparent higher transplantability of mela-
noma cells after subculture in vitro may
Melanoma
No.
VI
H71-1843
RVC 347
H73-1357
H73-858
Passage
4th
4th
16th
37th
19th
6th
22nd
22nd
22nd
40th
40th
82nd
82nd
82nd
82nd
82nd
Cell line
Cell line
Cell line
Cell line
Cell line
14th
14th
18th
18th
18th
3 x 107
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Fia. 3. Transplanted H73-858 melanoma cells. Iv. inoculation of melanoma cells which ha(l
become amelanotic during subcultivation in vitro produiced disseminated pleiomorphic melanotic
tumours (Nodule in thymus shown). Haematoxylin and eosin. x 160.
have resulted from selection of more
rapidly dividing cells in tissue culture, but
the direct and cell culture transplantation
series were not directly comparable.
Some considerable variation indevelop-
ment time was observed between tumours.
As no effort was made to match histo-
compatibility antigens between doniors and
recipients, random variations in anti-
genic disparity were to be expected. Pos-
sible failure of immunosuppression during
long periods of ALS administration could
therefore have produced litter-associated
failures in transplantation following in-
activation of the ALS by antiglobulin
produced by the recipients. Similarly,
cytotoxic anti-DL-A antibodies of the
donor specificities could be produced in the
xenogeneic ALS, according to the DL-A
type of the immunizing lymphoid cells.
Such antibodies could thus selectively
inhibit tumour cell growth without pro-
ducing toxicity in the recipients dependent
on DL-A specificities. This aspect will be
investigated in future studies.
The distribution pattern of tumours
after i.v. inoculation indicated the cardio-
pulmonary capillary bed as the principal
site of tumour cell lodgement. This
finding was supported by the distribution
of i.v. injected 51Cr-labelled melanoma
cells (Betton, 1975) after 1 h. Similar
findings were reported by Fisher and
Fisher (1967) for other species. The dis-
seminated spread of cells to extrapul-
monary sites in some dogs could have
resulted from the degree of trypsinization
and the presence of cell aggregates, as
reported for the murine B16 melanoma by
Hagmar and Norrby (1973). In the case
ofthe RVC 347 melanoma, some recipients
failed to develop rapidly fatal pulmonary
tumours, but later produced tumours in
sites such as bone and neural tissue.
The reversion of H73-858 cells to
melanin synthesis in vrivo indicated that
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FiG. 4. S.c. transplanted H71-1843 melanoma. Local inoculation of tissue culture H71-1843 cells
produced a rapidly growing amelanotic tumour. The anaplastic tumour cells showed a high pro-
portion of mitotic figures. Haematoxylin and eosin. x 635.
loss of pigment formation in vitro may be
produced by deficiencies in culture con-
ditions and is not an irreversible change.
The progressive growth in vivo, follow-
ing inoculation of canine melanoma cells
cultivated in vitro for various numbers of
passages, in a substantial proportion of
recipients was considered confirmatory of
the malignant nature of such cells. In
vitro features of malignancy, such as
morphology and agglutination by the
lectin Concanavalin A (Betton, in prepara-
tion) support this conclusion. No definite
effect of passage number on the trans-
plantability of melanoma cells was ob-
served. Primary cultures or cell lines of
normal canine cells have never produced
tumours after transplantation into identi-
cally treated allogeneic recipients in this
laboratory.
The availability of spontaneous canine
melanoma in vitro and in vivo willfacilitate
comparative studies on melanoma in
progress.
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